Source:http://linkedlifedata.com/resource/pubmed/id/21784976
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-8-22
|
pubmed:abstractText |
Mycobacterium tuberculosis is a virulent intracellular pathogen that survives in macrophages even in the presence of an intact adaptive immune response. Type I IFNs have been shown to exacerbate tuberculosis in mice and to be associated with disease progression in infected humans. Nevertheless, the mechanisms by which type I IFNs regulate the host response to M. tuberculosis infection are poorly understood. In this study, we show that M. tuberculosis induces an IFN-related gene expression signature in infected primary human macrophages, which is dependent on host type I IFN signaling as well as the mycobacterial virulence factor, region of difference-1. We further demonstrate that type I IFNs selectively limit the production of IL-1?, a critical mediator of immunity to M. tuberculosis. This regulation occurs at the level of IL1B mRNA expression, rather than caspase-1 activation or autocrine IL-1 amplification and appears to be preferentially used by virulent mycobacteria since avirulent M. bovis bacillus Calmette-Guérin (BCG) fails to trigger significant expression of type I IFNs or release of mature IL-1? protein. The latter property is associated with decreased caspase-1-dependent IL-1? maturation in the BCG-infected macrophages. Interestingly, human monocytes in contrast to macrophages produce comparable levels of IL-1? in response to either M. tuberculosis or BCG. Taken together, these findings demonstrate that virulent and avirulent mycobacteria employ distinct pathways for regulating IL-1? production in human macrophages and reveal that in the case of M. tuberculosis infection the induction of type I IFNs is a major mechanism used for this purpose.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1550-6606
|
pubmed:author |
pubmed-author:CardoneMarcoM,
pubmed-author:FengCarl GCG,
pubmed-author:KirschmanKevin DKD,
pubmed-author:Mayer-BarberKatrin DKD,
pubmed-author:MyersTimothy GTG,
pubmed-author:NovikovAlekseyA,
pubmed-author:RabinRonald LRL,
pubmed-author:ShenderovKevinK,
pubmed-author:SherAlanA,
pubmed-author:ThompsonRobertR,
pubmed-author:TrinchieriGiorgioG
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
187
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2540-7
|
pubmed:meshHeading |
pubmed-meshheading:21784976-Blotting, Western,
pubmed-meshheading:21784976-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21784976-Gene Expression,
pubmed-meshheading:21784976-Gene Expression Regulation,
pubmed-meshheading:21784976-Humans,
pubmed-meshheading:21784976-Interferon Type I,
pubmed-meshheading:21784976-Interleukin-1beta,
pubmed-meshheading:21784976-Macrophages,
pubmed-meshheading:21784976-Mycobacterium tuberculosis,
pubmed-meshheading:21784976-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21784976-Signal Transduction
|
pubmed:year |
2011
|
pubmed:articleTitle |
Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1? production in human macrophages.
|
pubmed:affiliation |
Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Intramural
|